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Abstract - The Brazilian Savanna (locally called “Cerrado”) is an important biome presenting several plants that are used 
in popular medicine. However, the risks associated with the consumption of derivatives from these plants are generally 
unknown. Studies with compounds obtained from different species have shown the risks of DNA damage. The present 
work assessed the in vivo mutagenicity of three plant species used in popular medicine to treat human gastrointestinal 
disorders (Mouriri pusa, Qualea grandiflora and Qualea multiflora). The micronucleus assay was performed in peripheral 
blood of mice submitted to acute treatments. Results showed that no assessed extracts were mutagenic in vivo. In fact, the 
absence of mutagenicity in the present study indicates that the extracts do not contain compounds capable of inducing 
DNA breaks or chromosomal loss. However, further analysis should be performed in others systems to guarantee their 
safety, mainly to human chronic use. 
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INTRODUCTION
According to the World Health Organization (WHO), 
about 80% of the world population uses medicinal 
plants or practice treatments suggested by traditional 
medicine (Basso et al., 2005). Several allopathic med-
icaments produced nowadays and consumed on a 
large scale are derived from natural products. About 
25% of the medicaments are prescribed worldwide 
and 11% of the medicaments are considered essen-
tial by the WHO are products derived from plants 
(Rates, 2001). 
However, the risks associated with the consump-
tion of natural products must be considered. It is im-
portant to note that natural plant extracts constitute 
complex mixtures of a great number of chemical sub-
stances, mainly organic compounds, and that some 
of these compounds may exhibit significant toxic-
ity. Furthermore, the concentrations of each of these 
compounds can vary pronouncedly, depending on 
the region, culture, weather, and others factors. In-
deed, different works have shown that several plants 
used  in  medical  practice  may  contain  substances 
that are toxic to organisms, inducing, for instance, 
DNA damage (Akintonwa et al., 2009; Stanic et al., 
2009; Verschaeve and Van Staden, 2008). Accord-
ing to Ames et al. (1983), plants utilized in diet and 
employed  in  medical  treatments  possess  chemical 
compounds that are capable of inducing mutations. 
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extracts and enriched fractions obtained from Bra-
zilian medicinal plants were mutagenic in vitro and 
in vivo (Santos et al., 2006a; Santos et al., 2008b). 
The Brazilian Savanna (locally called “Cerrado”) 
is  an  important  biome  presenting  approximately 
7000 vegetal species. Studies carried out with the nat-
ural products obtained from the plants of this biome 
have demonstrated important biological activities in 
different systems (Lira et al., 2008; Mazzolin et al., 
2010). However, the inherent risks associated with 
the use of medicinal plants should not be overlooked. 
In the present study we examined the mutagenicity 
produced by three vegetable species from Cerrado 
used  in  popular  medicine  to  treat  gastrointestinal 
disorders, such as diarrhea with blood and intestinal 
colic (Gaspi et al., 2006; Pott and Pott, 1994). This 
was evaluated in vivo using the micronucleus assay 
of peripheral blood cells of mice submitted to acute 
treatment. 
MATERIALS AND METHODS
Species evaluated and extract obtaining
In the present study, three vegetal species from Cer-
rado were evaluated: Mouriri pusa Gardner (Melasto-
mataceae), Qualea grandiflora Mart. (Vochysiaceae) 
and Qualea multiflora Mart. (Vochysiaceae). 
Leaves of M. pusa were collected in the district 
of Brejinho de Nazaré (Tocantins State, Brazil). A 
voucher specimen was kept in the University of To-
cantins (UNITINS) herbarium (No. 4548). The bark 
of  Q.  grandiflora  and  Q.  multiflora  were  collected 
at Pedro Afonso Road (Tocantins State, Brazil) and 
identified by Solange de Fatima Lolis (UNITINS). 
The voucher specimens were kept in the University 
of Tocantins herbarium (No. 3379 and No. 4158, re-
spectively).
The leaves of M. pusa and bark of Q. grandiflora 
and Q. multiflora were air-dried and powdered. In-
dividually, these vegetal materials were exhaustively 
extracted with methanol (48 h) at room temperature. 
The solvent was evaporated at 60ºC, under reduced 
pressure, in order to obtain the four different metha-
nol extracts evaluated in this study. The yield of the 
extraction process is presented in Table 1.
Micronucleus assay
To perform the micronucleus assay, blood samples 
from five to six week-old albino Swiss mice (Mus 
musculus), weighing approximately 30 g, from the 
Central  Animal  Facility  of  the  State  University  of 
Londrina (Parana – Brazil) were used. The animals 
were kept individually in polypropylene cages fol-
lowing the conditions for animal care recommended 
by the Canadian Council on Animal Care (Olfert et 
al., 1993). All the procedures were approved by the 
Ethics in Research Committee of the São Paulo State 
University in Araraquara (UNESP, SP, Brazil).
The mice were divided into eleven groups of ten 
animals (5 males and 5 females) for the evaluation 
of the different vegetable extracts: a negative con-
trol group, which receive distilled water, a positive 
control group, treated with cyclophosphamide (40 
mg Kg-1 body weight (b.w.)) and nine groups that re-
ceived the vegetal extracts. Each extract was assessed 
in three different doses: M. pusa – 665.0, 997.5 and 
1330 mg Kg-1 b.w.; Q. grandiflora – 909.0, 1363.0 and 
1818 mg Kg-1 b.w.; Q. multiflora – 855.8, 1283.7 and 
1711.6 mg Kg-1 b.w. These doses were based in the 
solubility limit of the extracts in distilled water, be-
ing that the dosages tested in the present work were 
not toxic to the animals. Each animal in these groups 
was treated with 0.1 mL of each test solution per 10 
g body weight. The animals received water and food 
ad libitum between the treatment and the blood sam-
pling. The treatments with plant extracts and with 
distilled water (negative control) were performed via 
gavage. The treatment with cyclophosphamide was 
performed intraperitoneally.  
The micronucleus test on peripheral blood cells 
was conducted as described by Hayashi et al. (Hay-
ashi et al., 1990). The animals received single doses 
of test solution (controls and vegetable extracts) 30 
h before the collection of blood samples. Blood was 
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with  a  needle  and  collecting  5  µL  drops,  each  of 
which was placed at the center of a pre-stained slide 
and covered with a coverslip (24 x 40 mm). 
The cell preparations were examined under a flu-
orescence microscope, with a blue (488 nm) excita-
tion filter and yellow (515 nm) emission (barrier) fil-
ter, using an oil-immersion objective. One thousand 
reticulocytes per treated animal were analyzed and 
the proportion of micronucleated cells was counted. 
For the statistical analysis, mean and standard devia-
tions were calculated and ANOVA was performed. 
The Tukey-Kramer test was employed to compare 
the results obtained for the treated groups with those 
of the negative control group.
RESULTS AND DISCUSSION
The secondary metabolites of plants may have bio-
logical activity variables, such as antibiotic, pesticide, 
repellent, controllers of cell division, among others 
(Mitscher et al., 1996). In this way, these activities 
can represent biological risks to organisms exposed 
to compounds obtained from vegetal sources. 
In  fact,  Ames  (Ames,  1983)  pointed  out  that 
many elements found in the human diet could have 
noxious  effects.  Other  studies  have  demonstrated 
that natural products can represent serious risks to 
the DNA integrity of different organisms (Calvo et 
al., 2011; Santos et al., 2010).
Such information underlines the importance of 
studying the genetic risks of plant compounds, espe-
cially in plants utilized by humans in the diet or in 
medicinal treatments. In the present study, we evalu-
ated the mutagenicity of four vegetal species from 
the Brazilian Cerrado, employing the micronucleus 
assay in peripheral blood of mice submitted to acute 
treatments. All the species analyzed are commonly 
applied in popular medicine to treat several diseases, 
especially those related to gastrointestinal disorders.
Data  presented  in  Table  2  show  that  none  of 
plant species assessed in this study was mutagenic in 
the micronucleus assay. All evaluated extracts were 
unable to induce DNA damage in mice submitted to 
acute treatment with different doses of these vegetal 
compounds. 
In M. pusa, as observed in our previous work 
(Santos et al., 2008b), the phenolic compound quer-
cetin  was  responsible  for  the  induction  of  DNA 
damage in Salmonella typhimurium assay. Howev-
er, herein we observed that the methanol extract of 
M. pusa was not mutagenic in vivo. This can be ex-
plained by the fact that the micronucleus assay iden-
tifies agents that cause DNA breaks or loss of whole 
chromosomes as the Salmonella typhimurium assay 
identifies agents that cause point mutations. Besides, 
according to Silva et al. (2002), quercetin aglycone, 
when evaluated at high doses, presents lower mu-
tagenicity in vivo compared to in vitro studies. This 
compound presents rapid degradation and elimina-
tion processes in vivo, which corroborates the expla-
nation of differences observed between in vivo and 
in vitro results.
The Q. grandiflora and Q. multiflora extracts, as 
discussed above, were not mutagenic in vivo. Phyto-
chemical studies with this vegetal species showed the 
presence of terpenes and saponins and, in agreement 
with the literature, the majority of these compounds 
are not mutagenic (Agner et al., 1999; Berhow et al., 
2000). In addition, studies have shown that some ter-
penes and plant extracts with these compounds in 
their phytochemical composition can present anti-
mutagenicity and antiapoptotic activities (Nikolic et 
al., 2011; Santos et al., 2006b; Santos et al., 2008a).
The use of plants with mutagenic potential in 
medical treatments can represent serious risks to pa-
tients since the mutations are closely related to the 
development of diseases such as cancer (De Flora, 
1998). The methodology employed herein permitted 
the identification of agents that are capable of induc-
ing  DNA  breakage  (clastogenesis)  or  mitotic  fails 
that result in chromosome loss (aneugenesis). The 
presented data show that the species evaluated in 
this study did not induce mutagenic effects in mice. 
However, these results cannot be considered a safety 
indicator for human consumption and further analy-194 F. V. SANTOS ET AL.
sis should be performed in other biological systems 
to guarantee their safety, especially chronic use of the 
extracts.
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